AMLX
USDAmylyx Pharmaceuticals Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$8.380
Kõrge
$8.500
Madal
$8.070
Maht
1.68M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
738.1M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.45M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025
- Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA Breakthrough Therapy designation, underway in post-bariatric hypoglycemia; completion of recruitment expected
Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market
Guggenheim initiates Amylyx at Buy with $17 price forecast, citing PBH drug avexitide's Phase 3 potential and $2 billion+ market opportunity.
Guggenheim Initiates Coverage On Amylyx Pharmaceuticals with Buy Rating, Announces Price Target of $17
Guggenheim analyst Seamus Fernandez initiates coverage on Amylyx Pharmaceuticals with a Buy rating and announces Price Target of $17.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.